An immunotherapy drug could prove just as effective as chemotherapy in prolonging the lives of patients with advanced cancers of the stomach or food pipe.
Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers
Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.
Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research.
People who are overweight in their twenties and become obese later in life may be three times more likely to develop oesophageal or upper stomach cancer.
We explore the second of our Grand Challenges and ask the experts if we can wipe out cancers caused by the Epstein-Barr Virus.
One in 10 stomach cancers appear to carry a genetic fingerprint which could provide clues as to the most effective course of treatment, new research suggests.
The world’s largest ever clinical trial looking at whether taking aspirin stops some of the most common cancers coming back, launches across the UK today.
A study published today, by Cancer Research UK-funded scientists, shows that cancer survival in England remains lower than in other similar countries – something first...
A short course of antibiotic treatment has the potential to reduce the risk of stomach cancer linked to infection with Helicobacter pylori bacteria.